PROTAC-E3 Ligase Ligands
Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptid
Product Description
PROTAC-E3 Ligase Ligands
Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.
Chemenu, founded in 2009, provides a wide variety of organic compounds and offers exclusive development for advanced intermediates. We manufacture building blocks, intermediates and novel compounds.Our goal is to support research projects for pharmaceutical and biotech companies, drug discovery centers, academic institutions and other research organizations worldwide.Part of the Linkchem Group, Chemenu can also supply CRO, CMO, CDMO services for R&D, process and commercial production.We are proud to be a reliable partner for our clients all over the world.
